Mesenchymal stem cell therapy in decompensated liver cirrhosis: a long-term follow-up analysis of the randomized controlled clinical trial

BACKGROUND: Mesenchymal stem cell (MSC) infusion was reported to improve liver function in patients with decompensated liver cirrhosis (DLC); however, whether the medication can improve outcome of these patients is poorly understood. METHODS: This prospective, open-labeled, randomized controlled stu...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Ming, Li, Yuan-Yuan, Xu, Ruo-Nan, Meng, Fan-Ping, Yu, Shuang-Jie, Fu, Jun-Liang, Hu, Jin-Hua, Li, Jing-Xin, Wang, Li-Feng, Jin, Lei, Wang, Fu-Sheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer India 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8651584/
https://www.ncbi.nlm.nih.gov/pubmed/34843069
http://dx.doi.org/10.1007/s12072-021-10199-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8651584/
https://www.ncbi.nlm.nih.gov/pubmed/34843069
http://dx.doi.org/10.1007/s12072-021-10199-2

Ejemplares similares